Allergen-induced upregulation of PD-L2 decreases IL-12 level and eventually aggravates airway hyperresponsiveness (AHR); while PD-L2 blockade dampens AHR development [2]. This evidence concerns the gene PDCD1LG2 and airway hyperresponsiveness.